Details for New Drug Application (NDA): 218722
The generic ingredient in SOLRIAMFETOL HYDROCHLORIDE is solriamfetol hydrochloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the solriamfetol hydrochloride profile page.
Summary for 218722
| Tradename: | SOLRIAMFETOL HYDROCHLORIDE |
| Applicant: | Alkem Labs Ltd |
| Ingredient: | solriamfetol hydrochloride |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 75MG BASE | ||||
| Approval Date: | Jun 17, 2026 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 150MG BASE | ||||
| Approval Date: | Jun 17, 2026 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
